Genitourinary Radiology: Page 79

Genitourinary Radiology: The Requisites
Genitourinary Radiology: The Requisites would serve as an excellent nuts-and-bolts review prior to boards.
October 3, 2004
Settlement in Immunomedics patent case
By AuntMinnie.com staff writers
Immunomedics has settled its patent infringement suit against Cytogen and C.R. Bard for an undisclosed payment and without any admission of fault or liability.
September 29, 2004
Tuberculosis: Managing an old disease with modern medicine
By N. Shivapriya
Contrary to perceptions that it's a disease of the past, tuberculosis is still a very real threat. Every year about 2 million people die from TB, and 6 million develop the active disease, according to estimates. The tuberculosis comeback has thrown radiologists a fresh set of challenges, but imaging findings can speed the diagnosis and treatment of this life-threatening disease.
August 11, 2004
2004 08 11 14 22 16 706
Cytogen notches record revenues
By AuntMinnie.com staff writers
Biopharmaceutical firm Cytogen reported record second-quarter revenues of $3.9 million, up 129.4% compared with the $1.7 million turned in a year ago. For the period (end-June 30), the Princeton, NJ-based vendor had a net loss of $4.4 million, compared with a net loss of $3.4 million in the second quarter of 2003.
August 5, 2004
To boldly go: Genitourinary ultrasound blasts into orbit
By Eric Barnes
Doctors and engineers at the National Aeronautics and Space Administration (NASA) have designed a remotely guided teleradiology system that enables them to perform ultrasound exams on their colleagues in space. The project began in a windswept Arctic crater, moved to zero-gravity testing aboard a suborbital aircraft, and finally to the International Space Station.
July 29, 2004
2004 07 22 15 03 40 706
Immunomedics scores favorable patent ruling
By AuntMinnie.com staff writers
Radiopharmaceutical firm Immunomedics said it has received a favorable ruling in its patent infringement suit against Cytogen of Princeton, NJ, and C.R. Bard of Covington, GA, relating to their ProstaScint agent.
June 24, 2004
Postsurgical radiation improves prostate cancer survival
By AuntMinnie.com staff writers
A 13-year study of prostate cancer patients who underwent radical prostatectomy found that those who receive radiation therapy within six months of surgery live longer than those who are left untreated.
June 21, 2004
CT gains ground in urology
By Eric Barnes
CT urography and cytoscopy are becoming the imaging team of choice for evaluating the urinary system, potentially replacing radiographic procedures such as intravenous or retrograde pyelography as often as 80% of the time, researchers report.
June 17, 2004
2004 06 14 12 09 23 706
Farewell to fusion: Contrast MRI edges CT in postbrachytherapy exams
By Eric Barnes
CT/MRI fusion is a waste of time for postbrachytherapy imaging of the prostate, say researchers from Boston and Vienna. Not only does contrast-enhanced MRI detect seeds nearly as well as CT, they say, but MRI’s superior soft-tissue contrast properties often make it the only way to tell whether seeds have migrated outside the organ.
May 18, 2004
2004 05 18 15 51 14 706
Point/counterpoint: Prostate cancer researchers battle over treatment options
By Eric Barnes
SAN FRANCISCO - Prostate cancer research loomed large at this week's American Urological Association meeting, echoing a stubbornly high prevalence of the disease among aging men. A debate over what to do after failed radiotherapy and brachytherapy earned points for another procedure often performed by radiologists: cryoablation of prostate cancer tumors.
May 13, 2004
SPECT/CT improves bladder cancer staging, management
By Eric Barnes
SAN FRANCISCO - In a poster presentation at this week’s American Urological Association meeting, Dr. Amir Sherif from Uppsala University in Sweden talked with AuntMinnie.com about a new fusion technique that more than doubled the sensitivity of planar lymphoscintigraphy alone.
May 11, 2004
2004 05 11 15 38 26 706
IsoRay inks deal with PNNL and U.S. DOE
By AuntMinnie.com staff writers
Medical isotope developer IsoRay has signed a manufacturing contract with Pacific Northwest National Laboratories (PNNL) and the U.S. Department of Energy (DOE) to collaborate in the manufacture of cesium-131 brachytherapy seeds, according to the Richland, WA-based firm.
May 10, 2004
Previous Page
Page 79 of 93
Next Page